Literature DB >> 21777613

Gut memories: towards a cognitive neurobiology of irritable bowel syndrome.

Paul J Kennedy1, Gerard Clarke, Eamonn M M Quigley, John A Groeger, Timothy G Dinan, John F Cryan.   

Abstract

The brain and the gut are engaged in continual crosstalk along a number of pathways collectively termed the 'brain-gut axis'. Over recent years it has become increasingly clear that dysregulation of the axis at a number of levels can result in disorders such as irritable bowel syndrome (IBS). With recent advances in neuroimaging technologies, insights into the neurobiology of IBS are beginning to emerge. However the cognitive neurobiology of IBS has remained relatively unexplored to date. In this review we summarise the available data on cognitive function in IBS. Moreover, we specifically address three key pathophysiological factors, namely; stress, immune activation and chronic pain, together with other factors involved in the manifestation of IBS, and explore how each of these components may impact centrally, what neurobiological mechanisms might be involved, and consider the implications for cognitive functioning in IBS. We conclude that each factor addressed could significantly impinge on central nervous system function, supporting the view that future research efforts must be directed towards a detailed assessment of cognitive function in IBS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21777613     DOI: 10.1016/j.neubiorev.2011.07.001

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  55 in total

1.  Healing Words: Using Affect Labeling to Reduce the Effects of Unpleasant Cues on Symptom Reporting in IBS Patients.

Authors:  Elena Constantinou; Katleen Bogaerts; Lukas Van Oudenhove; Jan Tack; Ilse Van Diest; Omer Van den Bergh
Journal:  Int J Behav Med       Date:  2015-08

Review 2.  The microbiome: stress, health and disease.

Authors:  Rachel D Moloney; Lieve Desbonnet; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Mamm Genome       Date:  2013-11-27       Impact factor: 2.957

3.  Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome.

Authors:  Kate Wolitzky-Taylor; Michelle G Craske; Jennifer S Labus; Emeran A Mayer; Bruce D Naliboff
Journal:  Behav Res Ther       Date:  2012-06-23

4.  A clinically relevant animal model of temporomandibular disorder and irritable bowel syndrome comorbidity.

Authors:  Richard J Traub; Dong-Yuan Cao; Jane Karpowicz; Sangeeta Pandya; Yaping Ji; Susan G Dorsey; Dean Dessem
Journal:  J Pain       Date:  2014-06-26       Impact factor: 5.820

Review 5.  Cross-species examination of single- and multi-strain probiotic treatment effects on neuropsychiatric outcomes.

Authors:  Jamie M Joseph; Catrin Law
Journal:  Neurosci Biobehav Rev       Date:  2018-11-22       Impact factor: 8.989

Review 6.  Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation.

Authors:  Eirini Dimidi; Stephanos Christodoulides; S Mark Scott; Kevin Whelan
Journal:  Adv Nutr       Date:  2017-05-15       Impact factor: 8.701

7.  Deep Brain Stimulation for Obsessive Compulsive Disorder Reduces Symptoms of Irritable Bowel Syndrome in a Single Patient.

Authors:  Berthold Langguth; Kornelia Sturm; Thomas C Wetter; Max Lange; Loes Gabriels; Emeran A Mayer; Juergen Schlaier
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-28       Impact factor: 11.382

Review 8.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour.

Authors:  John F Cryan; Timothy G Dinan
Journal:  Nat Rev Neurosci       Date:  2012-09-12       Impact factor: 34.870

9.  [Etiopathogenetic aspects of somatoform disorders].

Authors:  M Noll-Hussong; H Gündel
Journal:  Nervenarzt       Date:  2012-09       Impact factor: 1.214

10.  Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial.

Authors:  Ji-Meng Zhao; Jin-Hua Lu; Xiao-Jun Yin; Lu-Yi Wu; Chun-Hui Bao; Xing-Kui Chen; Yue-Hua Chen; Wei-Jun Tang; Xiao-Ming Jin; Huan-Gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2018-05-11       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.